Uniphar

Uniphar Interest Coverage

The Interest Coverage Ratio of Uniphar (UPR.IR) as of Oct 11, 2026 is 3.79. In the previous year, Interest Coverage Ratio was 3.55 — a change of 6.87% (higher).

Interest Coverage

3.79

YoY

6.87%

Last updated:

Interest Coverage Ratio of Uniphar is 2024 3.79 . Interest Coverage Ratio of Uniphar was 2023 3.55 . It decreases by 6.87% higher compared to the previous year.

The Uniphar Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
3.77 EUR
Jan 1, 2018
9.12 EUR
Jan 1, 2019
6.25 EUR
Jan 1, 2020
5.86 EUR
Jan 1, 2021
6.76 EUR
Jan 1, 2022
5.58 EUR
Jan 1, 2023
3.55 EUR
Jan 1, 2024
3.79 EUR
The Uniphar Interest Coverage history
YEARInterest CoverageYoY
3.79+6.87%
3.55-36.40%
5.58-17.57%
6.76+15.39%
5.86-6.23%
6.25-31.46%
9.12+142.21%
3.77-30.02%
5.38—
Access this data via the Eulerpool API

Uniphar Stock analysis

What does Uniphar do? Uniphar PLC is an Irish company that was founded in 1994 and operates in the healthcare industry. The company is headquartered in Dublin and employs over 2,500 people worldwide. The history of Uniphar began as a pharmacy distribution company that supplied medications to retailers and healthcare facilities. Over the years, however, the company has expanded its business model and now offers a wide range of healthcare products and services. Uniphar's business model encompasses three main areas: Healthcare Services, Commercial & Clinical Supply Chain, and Product Access & Specialty Medicines. In the Healthcare Services area, Uniphar provides consulting services, training, and leadership coaching for healthcare facilities. The Commercial & Clinical Supply Chain division includes the storage, logistics, and distribution of medications, as well as the clinical care of patients. The Product Access & Specialty Medicines division focuses on access to medications with high medical demand and rare diseases. Uniphar also offers a wide range of healthcare products, including generics, branded medications, and medical devices. The company has partnerships with leading pharmaceutical companies such as Pfizer, Eli Lilly, and Merck. In recent years, Uniphar has also made several significant acquisitions to expand and diversify its business. In 2018, the company acquired UK-based pharmaceutical distributor Cahill May Roberts, and in 2019, the acquisition of Durbin, an international supplier of clinical supply products, was completed. Uniphar is committed to improving healthcare in Ireland and worldwide and offers a wide range of products and services to achieve this goal. The company has earned a reputation as a reliable partner for healthcare facilities and pharmaceutical companies and is on a steady growth trajectory. Uniphar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniphar stock

Interest Coverage Ratio of Uniphar is 3.79 in 2024.

Interest Coverage Ratio of Uniphar changed from 3.55 to 3.79, representing a 6.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Uniphar since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Uniphar with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Uniphar

All Key Metrics — Uniphar